We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

128 hedge funds and large institutions have $625M invested in IDEAYA Biosciences in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

80% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 30

9% more funds holding

Funds holding: 117 → 128 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.34% less ownership

Funds ownership: 95.52% → 94.18% (-1.3%)

24% less capital invested

Capital invested by funds: $822M → $625M (-$196M)

Holders
128
Holders Change
+11
Holders Change %
+9.4%
% of All Funds
2.04%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
54
Reduced
30
Closed
11
Calls
$82K
Puts
–
Net Calls
+$82K
Net Calls Change
-$6.7M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.91M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$5.15M
3
BI
BVF Inc
California
+$4.17M
4
OM
Opaleye Management
Massachusetts
+$3.4M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.07M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$13.9M
2
5VM
5AM Venture Management
California
-$5.46M
3
LGM
Logos Global Management
California
-$5M
4
State Street
State Street
Massachusetts
-$3.47M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
26
Opaleye Management
Massachusetts
$4.71M +$3.4M +204,200 +147%
Axa
27
Axa
France
$4.67M -$12.5K -753 -0.2%
Two Sigma Investments
28
Two Sigma Investments
New York
$4.45M +$3.07M +184,447 +132%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$3.87M +$2.61M +156,500 +125%
CS
30
Candriam SCA
Luxembourg
$3.54M – – –
NCM
31
Nantahala Capital Management
Connecticut
$3.48M – – –
N
32
Nuveen
North Carolina
$3.28M -$3M -180,082 -43%
Goldman Sachs
33
Goldman Sachs
New York
$2.63M +$515K +30,898 +19%
Bank of America
34
Bank of America
North Carolina
$2.41M +$90.1K +5,410 +3%
First Manhattan
35
First Manhattan
New York
$2.27M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.11M +$21.5K +1,288 +0.8%
UOC
37
UBS O'Connor
Illinois
$1.91M +$2.31M +138,949 New
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.75M -$444K -26,630 -17%
Charles Schwab
39
Charles Schwab
California
$1.64M +$17.7K +1,065 +0.9%
Norges Bank
40
Norges Bank
Norway
$1.61M -$335K -20,100 -15%
Citigroup
41
Citigroup
New York
$1.43M +$567K +34,023 +49%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$1.33M +$1.27M +76,118 +363%
Ensign Peak Advisors
43
Ensign Peak Advisors
Utah
$1.27M – – –
Morgan Stanley
44
Morgan Stanley
New York
$1.25M +$544K +32,635 +56%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.14M -$163K -9,800 -11%
CSS
46
Cubist Systematic Strategies
Connecticut
$1.01M +$118K +7,086 +11%
SCM
47
Sio Capital Management
New York
$961K – – –
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$950K +$86.2K +5,177 +8%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$877K +$854K +51,289 +407%
Jane Street
50
Jane Street
New York
$867K +$825K +49,496 +362%
1
2
3 4 5

IDYA Hedge Fund Activity: Q1 2023 in Review

128 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2023, worth a combined $625M — down 24% from $822M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new IDYA positions and 11 closed out — a net gain of 11 holders — while 54 added to existing stakes and 30 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $7.91M. The largest seller was Baker Bros. Advisors, cutting an estimated $13.9M.

  • 128 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2023, up from 117 in Q4 2022.
  • Funds reported $625M of IDEAYA Biosciences stock for Q1 2023, down 24% quarter-over-quarter.
  • 22 funds opened new IDEAYA Biosciences positions in Q1 2023 and 11 closed out, a net change of +11 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2023 was Adage Capital Partners, an estimated $7.91M added.
  • The largest IDEAYA Biosciences seller in Q1 2023 was Baker Bros. Advisors, an estimated $13.9M sold.

Based on aggregated 13F filings for Q1 2023.